Moxifloxacin (Compound)

Synonyms:moxifloxacin, 151096-09-2, 1-Cyclopropyl-6-fluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid, Moxeza, Zimoxin, Avelox IV, 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4aS,7aS)-octahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-3-quinolinecarboxylic acid, 7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid, BAY 12-8039, U188XYD42P, CHEBI:63611, Izilox, Moxifloxacin (INN), (1'S,6'S)-1-Cyclopropyl-7-(2,8-diazabicyclo[4.3.0]non-8-yl)-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid, 7-[(4aS,7aS)-octahydro-1H-pyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid, Moxifloxacine, Avolex, MOXIFLOXACIN [INN], Moxifloxacin [INN:BAN], 1-Cyclopropyl-6-Fluoro-8-Methoxy-7-[(4as,7as)-Octahydro-6h-Pyrrolo[3,4-B]pyridin-6-Yl]-4-Oxo-1,4-Dihydroquinoline-3-Carboxylic Acid, MFX, 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-, 7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-quinoline-3-carboxylic acid, MXFX, BAY-128039, Actira (*Hydrochloride*), Avelox (*Hydrochloride*), moxyfloxacin, UNII-U188XYD42P, CCRIS 8690, MFCD04117996, HSDB 8026, 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4aS,7aS)-octahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-, Avelox IV (TN), (4R,7R)-Moxifloxacin, MOXIFLOXACIN [MI], MOXIFLOXACIN [VANDF], SCHEMBL24007, NAPROXENDIISOPROPYLAMIDE, MOXIFLOXACIN [WHO-DD], DTXSID3048491, GTPL10915, EX-A016, HMS3715P05, 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid, BCP22895, RKL10080, BAY128039, BDBM50366824, HY-66011A, NSC782304, s5535, BAY 12-8039 (*Hydrochloride*), AKOS015895251, AM84644, BCP9000962, CCG-221192, CS-1895, DB00218, NSC-782304, NCGC00271749-08, AC-25913, AS-41986, MXF, BCP0726000137, SBI-0206792.P001, D08237, AB00171653-11, AB00171653-13, AB00171653-14, AB00171653_15, EN300-1726094, AR-270/43507941, Q424940, SR-01000763482, SR-01000763482-3, 1-Cyclopropyl-6-fluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylicacid, 1-cyclopropyl-6-fluoro-8-methoxy-7-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid, 3-Quinolinecarboxylic acid,1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-
Pubchem:PUBCHEM:152946
Id:2597070b-0d54-5973-9256-c2ecb6cfd401
Description:nan

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Moxifloxacin's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Moxifloxacin.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Moxifloxacin.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.